GL1X · GenesisL1 explorer

MolNFT v1 · #178889 · protein

Crystal structure of bbki complexed with human kallikrein 4

7JOW · Kallikrein 4 (prostase, enamel matrix, prostate), isoform…: “Crystal structure of bbki complexed with human kallikrein 4”. X-ray diffraction, 3 ligands (URE, CD, CL), 3 pockets (best druggability 0.51). MolNFT v1 #178889 on…

PDB
7JOW
Type
protein
Length
387 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kallikrein 4 (prostase, enamel matrix, prostate), isoform CRA_A; Kunitz-type inihibitor
UniProt
A0A0C4DFQ5, Q6VEQ7
Ligands
URE, CD, CL
Pockets
3 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
EKallikrein 4 (prostase, enamel matrix, prostate), isoform CRA_Aprotein22312% helix, 36% strandA0A0C4DFQ5
IKunitz-type inihibitorprotein1640% helix, 48% strandQ6VEQ7

Ligands and binding sites

  • URE · Urea · ligand · chains E, I
  • CD · Cadmium ion · metal · chains E
  • CL · Chloride ion · ion · chains I
  • 2PE · Nonaethylene glycol · additive · chains E, I

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1850.510.8319URE
21960.480.7536empty
31090.450.7920empty

Interfaces

1 interface between chains.

  • E–I · 1072 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 7JOW · Crystal structure of BbKI complexed with Human Kallikrein 4 · the same entry in another collection · chain E against E, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.